Document is current
Any future updates will be listed below
-
Authors
Morgante, Francesca https://orcid.org/0000-0002-9834-3639
Oppo, Valentina
Fabbri, Margherita
Olivola, Enrica
Sorbera, Chiara
De Micco, Rosa
Ielo, Giovanna Chiara
Colucci, Fabiana
Bonvegna, Salvatore
Novelli, Alessio
Modugno, Nicola
Sensi, Mariachiara
Zibetti, Maurizio
Lopiano, Leonardo
Tessitore, Alessandro
Pilleri, Manuela
Cilia, Roberto
Elia, Antonio E.
Eleopra, Roberto
Ricciardi, Lucia
Cossu, Giovanni
-
Funding
Funding for this research was provided by:
St. George's University of London
- License Information
-
More Information
Article History
Received: 28 June 2020
Revised: 22 November 2020
Accepted: 4 December 2020
First Online: 22 December 2020
Compliance with ethical standards
:
: Francesca Morgante: Speaking honoraria from Abbvie, Medtronic, Zambon, Bial, Merz; Travel grants from the International Parkinson’s disease and Movement Disorder Society; Advisory board fees from Merz; Consultancies fees from Boston Scientific, Merz and Bial; Research support from Boston Scientific, Merz and Global Kynetic; Royalties for the book “Disorders of Movement” from Springer; member of the editorial board of Movement Disorders, Movement Disorders Clinical Practice, European Journal of Neurology. Giovanni Cossu: Speaking honoraria from UCB Pharma, Bial, AbbVie, Zambon, Boston. Research support from “Fondazione di Sardegna”. Roberto Cilia: Speaking honoraria from Zambon; Consultancies fees from Roche, Bial, Z-cube; travel grants for congresses from Boston Scientific and Abbvie. Margherita Fabbri: Speaking honoraria from Abbvie. Leonardo Lopiano: Speaking honoraria from UCB Pharma, AbbVie, DOC, Zambon and Bial. Nicola Modugno: Speaking honoraria from Abbvie, UCB, Zambon and Bial. Manuela Pilleri: Speaking honoraria and advisory board fees from Abbvie, UCB, Zambon, Boston Scientific, Abbot. Lucia Ricciardi: Research support from UK’s Medical Research Council (MRC), Clinical Academic Research Partnerships. Mariachiara Sensi: Speaking honoraria from Abbvie and Bial. Alessandro Tessitore: Speaking honoraria from Zambon, UCB pharma, Abbvie, Lusofarmaco, Bial. Maurizio Zibetti: Speaking honoraria from Medtronic, UCB Pharma, AbbVie, and Merz Pharma. Valentina Oppo, Enrica Olivola, Chiara Sorbera, Rosa De Micco, Salvatore Bonvegna, Fabiana Colucci, Alessio Novelli, Giovanna Chiara Ielo, Antonio E. Elia, Roberto Eleopra: no disclosures.
: Institutional ethics approval was obtained in the Coordinator Centre (AOU Brotzu, Cagliari, Pr. PG 2017/17817) and approved by the ethical Committees of all participating centers. The study was conducted in accordance with the Good Clinical Practice and the International Conference on Harmonization guidelines and any applicable national and local regulations. The authors acted in accordance with the Declaration of Helsinki ethical standards.
